Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles.

Int J Mol Sci

Oncological and Radiological Sciences Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Kepala Batas 13200, Penang, Malaysia.

Published: August 2021

Thymoquinone has anti-cancer properties. However, its application for clinical use is limited due to its volatile characteristics. The current study aims to develop a polymeric nanoformulation with PLGA-PEG and Pluronics F68 as encapsulants to conserve thymoquinone's (TQ) biological activity before reaching the target sites. Synthesis of nanoparticles was successfully completed by encapsulating TQ with polymeric poly (D, L-lactide-co-glycolide)-block-poly (ethylene glycol) and Pluronics F68 (TQ-PLGA-PF68) using an emulsion-solvent evaporation technique. The size and encapsulation efficiency of TQ-PLGA-PF68 nanoparticles were 76.92 ± 27.38 nm and 94%, respectively. TQ released from these encapsulants showed a biphasic released pattern. Cytotoxicity activity showed that tamoxifen-resistant (TamR) MCF-7 breast cancer cells required a higher concentration of TQ-PLGA-PF68 nanoparticles than the parental MCF-7 cells to achieve IC ( < 0.05). The other two resistant subtypes (TamR UACC732 inflammatory breast carcinoma and paclitaxel-resistant (PacR) MDA-MB 231 triple-negative breast cell line) required a lower concentration of TQ-PLGA-PF68 nanoparticles compared to their respective parental cell lines ( < 0.05). These findings suggest that TQ encapsulation with PLGA-PEG and Pluronics F68 is a promising anti-cancer agent in mitigating breast cancer resistance to chemotherapeutics. In future studies, the anti-cancer activity of TQ-PLGA-PF68 with the standard chemotherapeutic drugs used for breast cancer treatment is recommended.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431343PMC
http://dx.doi.org/10.3390/ijms22179420DOI Listing

Publication Analysis

Top Keywords

pluronics f68
12
tq-plga-pf68 nanoparticles
12
breast cancer
12
plga-peg pluronics
8
concentration tq-plga-pf68
8
nanoparticles
5
tq-plga-pf68
5
breast
5
formulation characterization
4
characterization cytotoxicity
4

Similar Publications

Poly(butyl cyanoacrylate) (PBCA) nanoparticles have numerous applications, including drug and gene delivery, molecular imaging, and cancer therapy. To uncover the molecular mechanisms underlying their interactions with cell membranes, we utilized a Langmuir monolayer as a model membrane system. This approach enabled us to investigate the processes of penetration and reorganization of PBCA nanoparticles when deposited in a phospholipid monolayer subphase.

View Article and Find Full Text PDF

Currently, materials with specific, strictly defined functional properties are becoming increasingly important. A promising strategy for achieving these properties involves developing methods that facilitate the formation of hierarchical porous materials that combine micro-, meso-, and macropores in their structure. Macropores facilitate effective mass transfer of substances to the meso- and micropores, where further adsorption or reaction processes can occur.

View Article and Find Full Text PDF

There is a growing pharmaceutical interest in supersaturated lipid-based formulations (Super-LbF) as an innovative strategy to enhance drug loading capacities while simultaneously reducing pill burden. This approach involves increasing the drug concentration above its equilibrium solubility in a lipid solution, achieved through temperature-induced supersaturation or the dissolution of lipophilic ionic salts. However, the physical instability and potential drug precipitation upon the dispersion of LbF remain critical.

View Article and Find Full Text PDF

A coloaded liposome in situ gel as a novel therapeutic strategy to treat cerebral ischemia reperfusion injury.

Brain Res

January 2025

Department of Neurology, Liaocheng People's Hospital, Liaocheng 252000, Shandong, China; Department of Neurology, Liaocheng People's Hospital, Shandong University, Jinan 250012, Shandong, China; Department of Neurology, the Second People's Hospital, Liaocheng, Liaocheng 252000, Shandong, China; State Key Laboratory of Dampness Syndrome of Chinese Medicine, Shandong Sub-centre, Liaocheng 252000, Shandong, China. Electronic address:

Background: Ischemic stroke has become one of the leading causes of death and disability worldwide in individuals aged 60 and above. However, currently available drugs show limited efficacy. Therefore, research to find more effective and safer therapeutic strategies is an urgent requirement for the treatment of cerebral ischemia reperfusion injury (CIRI).

View Article and Find Full Text PDF

Inhibition of Angiogenesis and Effect on Inflammatory Bowel Disease of Ginsenoside Rg3-Loaded Thermosensitive Hydrogel.

Pharmaceutics

September 2024

Department of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China.

Article Synopsis
  • Inflammatory bowel disease (IBD) is marked by chronic inflammation in the digestive tract and involves blood vessel formation (angiogenesis) as a key factor in its progression.
  • Ginsenoside Rg3 from ginseng has anti-angiogenic effects but suffers from poor absorption in the body, prompting the development of a new delivery system using a thermosensitive hydrogel called Gel-Rg3, made with Pluronic F-127 and F-68.
  • Gel-Rg3 demonstrated better safety and effectiveness against IBD in lab tests and mouse models by promoting drug retention in the intestine and inhibiting harmful blood vessel formation, offering new treatment strategies for managing IBD.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!